Psoriasis Treatment Center of Central New Jersey
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Psoriasis Treatment Center of Central New Jersey sits in the top decile of US sponsors by registered trial count (#886 of 15,742 sponsors by registered trial count).
Psoriasis Treatment Center of Central New Jersey: 16 sponsored US clinical trials, 8 recruiting.
Psoriasis Treatment Center of Central New Jersey sponsors 16 registered US clinical trials on ClinicalTrials.gov, 8 of them currently recruiting, and 7 completed. 14 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Psoriasis, with 5 trials.
Top-decile sponsor footprint
Psoriasis Treatment Center of Central New Jersey ranks in the top decile of sponsors by registered trial count (#886 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
16 total, page 1 of 1
Upadacitinib for Prurigo Nodularis
NCT06773403
Cryotherapy in Combination with Red Light PDT for Actinic Keratosis of Full Face
NCT06745999
Dupixent and Narrowband UVB for Atopic Dermatitis
NCT05285839
Taltz in Combination With Enstilar for Psoriasis
NCT04372277
ILUMYA in Combination With HALOG Ointment 0.1% for Plaque Psoriasis.
NCT04347473
Duobrii in Combination With Biologics
NCT04119102
Enstilar in Combination With Enbrel or Humira for Plaque Psoriasis
NCT03827876
An Open-Label, Pilot Study to Evaluate the Efficacy of Narrowband Ultraviolet-B Phototherapy Three Times Weekly for Twelve Weeks in Moderate-to-Severe Psoriasis Patients
NCT03392337
Tralokinumab for Dupilumab Failures
NCT06773455
Vtama in Psoriasis Patients Being Treated With Biologics.
NCT06103695
Combination of Sotyktu and Enstilar for Plaque Psoriasis
NCT06329258
An Outcomes Study to Determine the Reasons Patients on Biologic Therapy Discontinue Treatment and Fail to Follow-up With Their Providers
NCT03964168
Evaluation of Add on Enstilar in Patients Using Otezla for Psoriasis
NCT03587194
Enstilar in Combination With Biologic Agents
NCT03080545
Topical Scalp Psoriasis Study Evaluating Topicort Topical Spray
NCT02985736
Apremilast 30mg Bid With Narrowband UVB in the Treatment of Plaque Psoriasis
NCT02412644
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 14 |
Therapeutic Areas
Where Psoriasis Treatment Center of Central New Jersey enrollment is open (later-stage tilt)
8 recruiting of 16 indexed (50% open); 7 completed (44%).
Phase mix: 14 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Psoriasis (5 trials), 3 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Psoriasis Treatment Center of Central New Jersey: open-pipeline peers nationwide
Peers matched on 16 registered trials and 50% open enrollment, not the therapeutic-area sidebar.
Psoriasis Treatment Center of Central New Jersey sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 16 trials (± recruiting share)
- Accelerated Community Oncology Research Network · 16 trials · 0% recruiting
- Altimmune · 16 trials · 6% recruiting
- American University · 16 trials · 13% recruiting
- Anthera Pharmaceuticals · 16 trials · 0% recruiting
Sponsors near 50% open enrollment (± trial volume)
- 1200 Pharma · 50% recruiting · 2 trials
- 1ST Biotherapeutics · 50% recruiting · 2 trials
- 3ive Labs · 50% recruiting · 2 trials
- 60 Degrees Pharmaceuticals · 50% recruiting · 4 trials
Related
What to do with this Psoriasis Treatment Center of Central New Jersey page
16 registered trials is a research-attention snapshot, not an endorsement of Psoriasis Treatment Center of Central New Jersey or any single study.
- 8 of Psoriasis Treatment Center of Central New Jersey's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Psoriasis is the condition Psoriasis Treatment Center of Central New Jersey studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Psoriasis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Psoriasis Treatment Center of Central New Jersey pipeline card: 16 registered trials from official public datasets.Report a data error.